Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Boston Scientific Corporation Bsx Gains 44 Ytd As Farapulse Launch Drives 17 Q2 Growth

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Corporation Bsx Gains 44 Ytd As Farapulse Launch Drives 17 Q2 Growth is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Boston Scientific Corporation Bsx Gains 44 Ytd As Farapulse Launch Drives 17 Q2 Growth | RobinsPost News & Noticias

Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & Supplies - Diversified Segment


Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best ... Read More

Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript


Good morning, and welcome to the Boston Scientific Second Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ... Read More

Boston Scientific Shares Gain Momentum on Strong Medical Device Performance


The medical technology sector is witnessing impressive growth from industry leader Boston Scientific, whose strategic initiatives and innovative cardiac tech ... Read More

Boston Scientific's Margins Strengthen in Q3: What's Driving It?


Boston Scientific BSX posted an adjusted gross margin of 71% in the third quarter of 2025, representing a 60-basis-point (bps) improvement compared to the prior-year period. The increase was mainly ... Read More

Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates


Boston Scientific (BSX) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.62 per share a year ago. These ... Read More

What’s Happening With BSX Stock?


CHONGQING, CHINA - APRIL 20: In this photo illustration, the logo of Boston Scientific Corporation is displayed on a smartphone screen, with the company's branding and slogan Advancing science for ... Read More

Analysts project durable growth with many near-term catalysts for Boston Scientific


Analysts remain high on Boston Scientific after a visit to the company's Marlborough, Massachusetts headquarters. Read More

Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained


Boston Scientific Corporation (NYSE:BSX) ranks among the best medical device stocks to invest in. Following an analyst visit to Boston Scientific Corporation (NYSE:BSX)’s headquarters, TD Cowen ... Read More

Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know


Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus